Gaymed Labs Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 11-12-2024
- Paid Up Capital ₹ 0.20 M
as on 11-12-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 11-12-2024
- Satisfied Charges ₹ 1.50 M
as on 11-12-2024
- Revenue %
(FY 2022)
- Profit 2155.68%
(FY 2022)
- Ebitda 106.17%
(FY 2022)
- Net Worth 6.67%
(FY 2022)
- Total Assets 3.99%
(FY 2022)
About Gaymed Labs
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.00 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Aman Arora and Aditya Bahl serve as directors at the Company.
- CIN/LLPIN
U24232DL1995PTC068951
- Company No.
068951
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 1995
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gaymed Labs Private Limited offer?
Gaymed Labs Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Contact Lenses, Lenses, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Eyewear, Sunglasses & Accessories, Eyeglasses Accessories, Common Disease Medicines, Eye Drops.
Who are the key members and board of directors at Gaymed Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman Arora  | Director | 21-Apr-2010 | Current |
| Aditya Bahl | Director | 01-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Gaymed Labs.
Gaymed Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2155.68% increase in profit. The company's net worth moved up by a moderate rise of 6.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gaymed Labs?
In 2020, Gaymed Labs had a promoter holding of 84.50% and a public holding of 15.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Feb 2019 | ₹1.00 M | Open |
Indian Bank Creation Date: 13 Nov 2014 | ₹1.50 M | Satisfied |
How Many Employees Work at Gaymed Labs?
Unlock and access historical data on people associated with Gaymed Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gaymed Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gaymed Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
